Wakix
| Chemical Name | pitolisant |
| Dosage Form | Tablet (oral; 4.45 mg, 17.8 mg) |
| Drug Class | Receptor antagonists |
| System | Nervous |
| Company | Harmony Biosciences |
| Approval Year | 2019 |
Indication
- Wakix is indicated for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.